The prognostic value of some clinical, radiological, laboratory and functional parameters in sarcoidosis;Wartość rokownicza wybranych wskaźników klinicznych, radiologicznych, biochemicznych I czynnościowych w przebiegu sarkoidozy u chorych nie leczonych

Pneumonologia i Alergologia Polska

Volumn 70, Issue 11-12, 2002, Pages 573-582

  Krychniak Soszka, Anna ^a   Kuś, Jan ^a  

^a Instytutu Gru licy i Chorób P uc w Warszawie   (Poland)

Author keywords

Prognostic factors; Remission; Sarcoidosis

Indexed keywords

CALCIUM; DIPEPTIDYL CARBOXYPEPTIDASE;

ADULT; AGE DISTRIBUTION; AGED; ARTHRITIS; ARTICLE; CHI SQUARE DISTRIBUTION; CORRELATION ANALYSIS; DRUG BLOOD LEVEL; ERYTHEMA NODOSUM; EYE DISEASE; FEMALE; FEVER; FUNCTIONAL ANATOMY; GENDER; GRANULOMATOSIS; HUMAN; HYPERCALCEMIA; HYPERCALCIURIA; MAJOR CLINICAL STUDY; MALE; OBSERVATION; ONSET AGE; PATTERN RECOGNITION; PREDICTION; PROGNOSIS; REMISSION; SARCOIDOSIS; SPLENOMEGALY; STATISTICAL ANALYSIS; STEROID THERAPY; SYMPTOMATOLOGY;

EID: 0036956511     PISSN: 08677077     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. American Thoracic Society: Statement on sarcoidosis. Am J Respir Crit Care Med 1999, 160, 736-755.
2. DeRemee R.A.: The roentgenographic staging of sarcoidosis. Historic and contemporary perspectives. Chest 1983, 83, 128-133.
3. Ellis K., Renthal G.: Pulmonary sarcoidosis. Roentgenographic observations on course of disease. Am J Roentgenol 1962, 88, 1070-1083.
4. Gibson G.J., Prescott R.J., Muers M.F. i wsp.: British Thoracic Society Sarcoidosis study: effects of long term corticosteroid treatment. Thorax 1996, 51, 238-247.
5. Grenier P., Brauner M., Valeyre D.: Computed tomography in the assessment of diffuse lung disease. Sarcoidosis Vasc Diffuse Lung Dis 1999, 16, 47-56.
6. Hillerdal G., Nou E., Osterman K., Schmekel B.: Sarcoidosis: epidemiology and prognosis. A 15-year European Study. Am Rev Respir Dis 1984, 130, 29-32.
7. Hunninghake G.W., Gilbert S., Pueringer R., i wsp.: Outcome of the treatment for sarcoidosis. Am J Respir Crit Care Med 1994, 149, 893-898.
8. Hunninghake G.W., Costabel U., Ando M., Baughman R., Cordier J.F., du Bois R., Eklund A., Kitaichi M., Lynch J., Rizzato G., Rose C., Selroos O., Semenzato G., Sharma O.P.: ATS/ERS/WASOG Statement on sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 1999, 16, 149-173.
9. James D.G.: Sarcoidosis and other granulomatous disorders. M. Dekker, New York, 1994.
10. James D.G.: Sarcoidosis w: James D.G., Zumla A.: The granulomatous disorders. Cambridge University Press, Cambridge 2000, 299-319.
11. James D.G.: Life-threatening situations in sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 1998, 15, 134-139.
12. Jóźwik A.: Metody statystycznego rozpoznawania obrazów. Zastosowania do analizy danych biomedycznych. w: Frank-Piskorska A. (red.): Aktualia 2000 w fizjopatologii i klinice oddychania. Warszawa, 2000, 238-245.
13. Klech H., Kohn H., Kummer F., Mostbeck A.: Assessment of activity in sarcoidosis. Sensivity and specifity of 67 gallium scintigraphy, serum ACE levels, chest roentgenography, and blood lymphocyte subpopulations. Chest 1982, 82, 732-738.
14. Leitch A.G.: Sarcoidosis w: Crofton and Douglass Respiratory Diseases, Seaton A., Seaton D., Leitch A.G., Blackwell Science, Oxford, 2000, 1035-1062.
15. Mana J., Salazar A., Manresa F.: Clinical factors predicting persistence of activity in sarcoidosis: a multivariate analysis of 193 cases. Respiration 1994, 61, 219-225.
16. Muller N.L., Miller R.R.: Computed tomography of chronic diffuse infiltrative lung disease. Am Rev Respir Dis 1990, 142, 1206-1215, 1440-1448.
17. Muller-Quernheim J.: Sarcoidosis: clinical manifestations, staging and therapy (partil). Respir Med 1998, 92, 140-149.
18. Muthuswamy P.P., Lopez-Majano V., Ranginwala M., Trainor W.D.: Serum angiotensin-converting enzyme (SACE) activity as an indicator of total body granuloma load and prognosis in sarcoidosis. Sarcoidosis 1987, 4, 142-148.
19. Nagai S., Shigematsu M., Hamada K., Izumi T.: Clinical courses and prognoses of pulmonary sarcoidosis. Curr Opin Pulm Med 1999, 5, 293-298.
20. Olszewicz-Dukaczewska M., Pruszyński B.: Kliniczna ocena stanowiska do zdjȩć klatki piersiowej Amber. Pol Przegl Radiol 1997, 62, 134-137.
21. Prior C., Barbee R.A., Evans P.M. i wsp.: Lavage versus serum measurements of lysozyme, angiotensin converting enzyme and other inflammatory markers in pulmonary sarcoidosis. Eur Respir J 1990, 3, 1146.
22. Reich J.M., Johnson R.E.: Course and prognosis of sarcoidosis in a nonreferral setting. Analysis of 86 patients observed for 10 years. Am J Med 1985, 78, 61-67.
23. Sawicki F.: Elementy statystyki dla lekarzy. PZWL, Warszawa, 1982.
24. Scadding J.G.: Prognosis of intrathoracic sarcoidosis in England. A review of 136 cases after five years observation. Br Med J 1961, 1165-1172.
25. Selroos O.: Bronchoalveolar lavage and biochemical markers in serum for monitoring disease activity and prognosis of sarcoidosis. Sarcoidosis 1992, 9, 145-146.
26. Sharma O.P.: Pulmonary sarcoidosis and corticosteroids. Am Rev Respir Dis 1993, 147, 1598-1600.
27. Sharma O.P.: Sarcoidosis. Clin Chest Med 1997, 18, 663-890.
28. Siltzbach L.E., James D.G., Neville E. i wsp.: Course and prognosis of sarcoidosis around the world. Am J Med 1974, 57, 847-852.
29. Stirling R.G., Cullinan P., Du Bois R.M.: Sarcoidosis w: Schwartz M.I., King T.E.: Interstitial lung diseases. B.C. Decker, Hamilton, 1998, 279-323.
30. Studdy P.R.: Sarcoidosis w: Respiratory Medicine. Brewis R.A.L. i wsp., W.B. Saunders, London 1995, 1403-1434.
31. Szlapin M., Pruszyński B., Szamowska R.: Badanie płuc za pomocá tomografii komputerowej o wysokiej rozdzielczości. Metoda badania i anatomia radiologiczna. Pol Przegl Radiol 1991, 55, 3-4, 73-75.
32. Tazi A., Desfemmes-Baleyte T., Soler P. i wsp.: Pulmonary sarcoidosis with a diffuse ground glass pattern on the chest radiograph. Thorax 1994, 49, 793-797.
33. Third meeting of the World Association of Sarcoidosis and Other Granulomatous Disorders, 1993: Consensus conference: activity of sarcoidosis. Eur Respir J 1994, 7, 624-627.
34. Thomas P.D., Hunninghake G.W.: Current concepts of the pathogenesis of sarcoidosis. Am Rev Respir Dis 1987, 135, 747-760.
35. Vestbo J., Viskum K.: Respiratory symptoms at presentation and long-term vital prognosis in patients with pulmonary sarcoidosis. Sarcoidosis 1994, 11, 123-125.
36. Viskum K., Vestbo J.: The prognosis of extrapulmonary sarcoidosis. Sarcoidosis 1994, 11, 73-75.
37. Viskum K., Vestbo J.: Vital prognosis intrathoracic sarcoidosis with special reference to pulmonary function and radiological stage. Eur Respir J 1993, 6, 349-353.
38. Ward K., O'Connor C., Odlum C., Fitzgerald M.X.: Prognostic value of bronchoalveolar lavage in sarcoidosis: the critical influence of disease presentation. Thorax 1989, 44, 6-12.
39. Winterbauer R.H.: Current concepts in and modes for measurement of activity in interstitial lung disease. Curr Opin Pulm Med 1995, 1, 358-362.
40. Winterbauer R.H., Kirtland S.H., Corley D.E.: Treatment with corticosteroids. Clin Chest Med 1997, 18, 843-851.
41. Ziegenhagen M.W., Benner U.K., Zissel G. i wsp.: Sarcoidosis: TNF-alfa release from alveolar macrophages and serum level of slL2R are prognostic markers. Am J Respir Crit Care Med 1997, 156, 1586-1592.
42. Ziora D., Grzanka P., Dobrowolski J. i wsp.: Badania czynnościowe płuc i skład komórkowy popłuczyn oskrzelowo-pȩcherzykowych u chorych na sarkoidozȩ I ze zmianami i bez zmian w tomografii komputerowej wysokiej rozdzielczosci. Pneumonol Alergol Pol 1996, 64, 715-722.